Log In
Print
BCIQ
Print
Print this Print this
 

DCVax-Prostate

  Manage Alerts
Collapse Summary General Information
Company Northwest Biotherapeutics Inc.
DescriptionAutologous dendritic cells treated ex vivo with prostate-specific membrane antigen (PSMA)
Molecular Target Prostate-specific membrane antigen (PSMA) (FOLH1) (GCPII)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase III
Standard IndicationProstate cancer
Indication DetailsTreat metastatic prostate cancer; Treat prostate cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today